Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China · Delayed Price · Currency is CNY 48.89
-0.99 (-1.98%)
At close: Jun 3, 2026
SHA:688765 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -160.81 | -151.37 | -186.96 | -143.58 | -134.04 | -53.35 |
Depreciation & Amortization | 61.44 | 61.44 | 47.82 | 12.92 | 10.04 | 10.11 |
Other Amortization | 0.4 | 0.4 | 0.01 | - | - | - |
Loss (Gain) From Sale of Assets | 1.28 | 1.28 | -1.01 | -0.33 | 11.27 | -2.08 |
Asset Writedown & Restructuring Costs | 0.48 | 0.48 | 1.11 | 1.3 | - | 0.06 |
Provision & Write-off of Bad Debts | 0 | 0 | 0.01 | -0.05 | 0 | 0.01 |
Other Operating Activities | -55.54 | 5.18 | 0.99 | 0.34 | 0.8 | 1.13 |
Change in Accounts Receivable | -9.95 | -9.95 | 18.19 | -7.88 | -21.29 | -2.36 |
Change in Inventory | -14.29 | -14.29 | -10.06 | -13.15 | 0.86 | -1.1 |
Change in Accounts Payable | 32.2 | 32.2 | -16.26 | 60.82 | 26.57 | -2.42 |
Change in Other Net Operating Assets | 21.1 | 21.1 | 23.32 | 23.2 | 17.82 | 14.81 |
Operating Cash Flow | -123.7 | -53.53 | -122.85 | -66.4 | -87.97 | -35.18 |
Capital Expenditures | -345.93 | -166.84 | -101.59 | -358.29 | -175.47 | -1.66 |
Sale of Property, Plant & Equipment | - | 40.48 | - | 0.68 | - | - |
Investing Cash Flow | -345.93 | -126.37 | -101.59 | -357.61 | -175.47 | -1.66 |
Long-Term Debt Issued | - | 133.55 | 77.98 | 30.4 | 9.9 | 12.6 |
Total Debt Issued | 442.56 | 133.55 | 77.98 | 30.4 | 9.9 | 12.6 |
Long-Term Debt Repaid | - | -23.5 | -1 | -16.27 | -20.29 | -14.23 |
Total Debt Repaid | -25.81 | -23.5 | -1 | -16.27 | -20.29 | -14.23 |
Net Debt Issued (Repaid) | 416.75 | 110.05 | 76.98 | 14.13 | -10.39 | -1.63 |
Issuance of Common Stock | - | - | - | 556.32 | 367.31 | 176.38 |
Common Dividends Paid | -11.65 | -4.63 | -1.18 | -0.74 | -0.66 | -1.07 |
Other Financing Activities | -8.15 | -1.15 | -3.17 | -1.58 | - | - |
Financing Cash Flow | 396.95 | 104.28 | 72.64 | 568.12 | 356.26 | 173.69 |
Foreign Exchange Rate Adjustments | -0.03 | 0.06 | 0.22 | 0.04 | -0.07 | -0.5 |
Net Cash Flow | -72.71 | -75.57 | -151.58 | 144.15 | 92.75 | 136.34 |
Free Cash Flow | -469.63 | -220.38 | -224.45 | -424.7 | -263.44 | -36.85 |
Free Cash Flow Margin | -2008.10% | -873.96% | -925.01% | -3169.45% | -1032.38% | -170.86% |
Free Cash Flow Per Share | -1.74 | -0.81 | -0.84 | -1.63 | -1.22 | -0.74 |
Cash Income Tax Paid | - | -1.59 | -27.87 | -44.15 | -1.72 | -0.44 |
Levered Free Cash Flow | - | -121.68 | -222.43 | -387.25 | -136.64 | -24.29 |
Unlevered Free Cash Flow | - | -118.49 | -222.01 | -387.11 | -136.31 | -23.68 |
Change in Working Capital | 29.05 | 29.05 | 15.19 | 62.99 | 23.95 | 8.94 |